Literature DB >> 6454378

Role of the 7 alpha-methoxy and side-chain carboxyl of moxalactam in beta-lactamase stability and antibacterial activity.

K Murakami, T Yoshida.   

Abstract

The effects of the alpha-carboxyl of the phenylmalonyl side chain and the 7 alpha-methoxy group in moxalactam (6059-S) (7 beta-[2-carboxy-2-(4-hydroxyphenyl) acetamido]-7 alpha-methoxy-3[[(1-methyl-1H-tetrazol-5-y])thio] methyl]-1-oxa-1-dethia-3-cephem-4-carboxylic acid) and in the 1-sulfur congener on the stability to beta-lactamase were investigated by spectrophotometric and microbiological assays. The 7 alpha-methoxy substituent stabilized the compounds against penicillinase hydrolysis, and the alpha-carboxyl group stabilized them against cephalosporinase. An exception is the beta-lactamase produced by Proteus vulgaris, an inducible cephalosporinase, which hydrolyzed compounds having the alpha-carboxyl group but not those having the 7 alpha-methoxy group. Both substituents exerted their stabilizing effects independently, and compounds with both substituents, e.g., moxalactam (6059-S) and its 1-sulfur congener, were resistant to both penicillinases and cephalosporinases. The stabilization of the compounds to beta-lactamase hydrolysis improved their antibacterial activity against beta-lactamase-producing strains.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454378      PMCID: PMC181347          DOI: 10.1128/AAC.19.1.1

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

2.  Kinetics of -lactamase inactivation of penicillins I: effect of side-chain structure, ionic strength, pH, and temperature.

Authors:  J P Hou; J W Poole
Journal:  J Pharm Sci       Date:  1973-05       Impact factor: 3.534

3.  Comparison of assay techniques for beta-lactamase activity.

Authors:  G W Ross; K V Chanter; A M Harris; S M Kirby; M J Marshall; C H O'Callaghan
Journal:  Anal Biochem       Date:  1973-07       Impact factor: 3.365

4.  Drug resistance of enteric bacteria. XIV. Comparison of beta-lactamases in gram-negative rod bacteria resistant to alpha-aminobenzylpenicillin.

Authors:  T Sawai; S Mitsuhashi; S Yamagishi
Journal:  Jpn J Microbiol       Date:  1968-12

5.  A comparative study of eight distinct beta-lactamases synthesized by gram-negative bacteria.

Authors:  G W Jack; M H Richmond
Journal:  J Gen Microbiol       Date:  1970-04

6.  Beta-lactam antibiotics from Streptomyces.

Authors:  R Nagarajan; L D Boeck; M Gorman; R L Hamill; C E Higgens; M M Hoehn; W M Stark; J G Whitney
Journal:  J Am Chem Soc       Date:  1971-05-05       Impact factor: 15.419

7.  The purification and properties of penicillin beta-lactamases mediated by transmissible R factors in Escherichia coli.

Authors:  S Yamagishi; K O'Hara; T Sawai; S Mitsuhashi
Journal:  J Biochem       Date:  1969-07       Impact factor: 3.387

8.  Penicillinases of Klebsiella pneumoniae and their phylogenetic relationship to penicillinases mediated by R factors.

Authors:  T Sawai; S Yamagishi; S Mitsuhashi
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

9.  The purification and properties of a penicillinase whose synthesis is mediated by an R-factor in Escherichia coli.

Authors:  N Datta; M H Richmond
Journal:  Biochem J       Date:  1966-01       Impact factor: 3.857

10.  The purification and some properties of a beta-lactamase (cephalosporinase) synthesized by Enterobactercloacae.

Authors:  T D Hennessey; M H Richmond
Journal:  Biochem J       Date:  1968-09       Impact factor: 3.857

View more
  3 in total

1.  Covalent binding of moxalactam to cephalosporinase of Citrobacter freundii.

Authors:  K Murakami; T Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

2.  7 alpha-formylamino substituent confers beta-lactamase-inactivating potency on 1-oxacephalosporins.

Authors:  K Murakami; M Doi; T Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

Review 3.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.